Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
KRIBB3 (5-(5-ethyl-2-hydroxy-4-methoxyphenyl)-4-(4-methoxyphenyl)
isoxazole
) inhibited cancer cell growth in vitro and in vivo. Flow cytometry studies showed that KRIBB3 caused cell cycle arrest at the G(2)/M phase and subsequent apoptosis. This was confirmed as accumulation of Cyclin B1 and cleavage of poly(ADP-ribose) polymerase (PARP) were detected. While transient inhibition by KRIBB3 led to reversible mitotic arrest, prolonged exposure to KRIBB3-induced apoptosis. Co-immunoprecipitation experiments showed that KRIBB3 initially induced association of inhibitory Mad2 with p55CDC (mammalian homologue of CDC20), an activator of
APC
/C (anaphase-promoting complex/cyclosome), suggesting that the mitotic spindle checkpoint was activated by KRIBB3. However, the level of this inhibitory complex of Mad2 with p55CDC was gradually decreased 24 h after KRIBB3 treatment, and was hardly detectable after 48 h, indicating some slipping of the mitotic checkpoint. Consistent with these observations, KRIBB3 activated the mitotic spindle checkpoint by disrupting the microtubule cytoskeleton. KRIBB3 was proven to be a tubulin inhibitor using in vitro polymerization assays and in vivo indirect immunofluorescence staining. The temporal pattern of Bax activation by KRIBB3 was similar to PARP cleavage, suggesting that Bax is a mediator of KRIBB3-dependent apoptosis. Furthermore, when KRIBB3 was administered intraperitoneally into nude mice at 50 mg/kg or 100 mg/kg, it inhibited 49.5 or 70.3% of tumor growth, respectively. These results suggest that KRIBB3 is a good drug candidate for cancer therapy.
...
PMID:KRIBB3, a novel microtubule inhibitor, induces mitotic arrest and apoptosis in human cancer cells. 1791 94
In the present study, we examined morphology and function of hippocampus in the
APC
1638T/1638T
mouse. Expression levels of the
APC
mRNA and protein were both identical in the hippocampus of the
APC
+/+
and
APC
1638T/1638T
mice. The dentate gyrus of the
APC
1638T/1638T
hippocampus was thicker, and has more densely-populated granule cells in the
APC
1638T/1638T
mouse hippocampus. Immunoelectron microscopy revealed co-localization of
APC
with alpha-amino-3- hydroxy-5-methyl-
isoxazole
-4-propionate receptor (AMPA-R) and with PSD-95 at post-synapse in the
APC
+/+
hippocampus, while APC1638T was co-localized with neither AMPA-R nor PSD-95 in the
APC
1638T/1638T
hippocampus. By immunoprecipitation assay, full-length
APC
expressed in the
APC
+/+
mouse was co-immunoprecipitated with AMPA-R and PSD-95. In contrast, APC1638T expressed in the
APC
1638T/1638T
mouse was not co-immunoprecipitated with AMPA-R and PSD-95. In the hippocampal CA1 region of the
APC
1638T/1638T
mouse, c-Fos expression after electric foot shock was decreased compared with the
APC
+/+
mouse. The present study showed some abnormalities on morphology of the hippocampus caused by a truncated
APC
(APC1638T). Also, our findings suggest that failure in
APC
binding to AMPA-R and PSD-95 may bring about less activities of hippocampal neurons in the
APC
1638T/1638T
mouse.
...
PMID:Morphological and functional abnormalities of hippocampus in APC
1638T/1638T
mice. 3257 22